-
NDRA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ENDRA Life Sciences (NDRA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm | 4.75 mm |
Cash burn (monthly) | 551.85 k | (no burn) | 784.70 k | 735.42 k | 552.41 k | 671.62 k |
Cash used (since last report) | 2.93 mm | n/a | 4.16 mm | 3.90 mm | 2.93 mm | 3.56 mm |
Cash remaining | 1.82 mm | n/a | 582.79 k | 844.19 k | 1.81 mm | 1.18 mm |
Runway (months of cash) | 3.3 | n/a | 0.7 | 1.1 | 3.3 | 1.8 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 14 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.35 mm |
Total shares | 15.84 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
L1 Capital Global Opportunities Master Fund | 7.92 mm | $673.00 k |
S.H.N. Financial Investments | 7.92 mm | $673.00 k |
Proequities | 0.00 | $0.00 |